Abstract：
BACKGROUND: The use of digital Patient- Reported Outcomes (PRO) tools has been shown to enhance the exchange of information and shared decision-making in medical encounters. However, their influence on patient-pharmacist interactions has not yet been explored.
OBJECTIVE: This study aimed to examine the impact of RxTalk™, a digital PRO tool, in supporting the communication between patients and pharmacists compared to usual care.
METHODS: Intervention: RxTalk™ was developed to collect information about medication adherence and beliefs, using a tablet computer.
METHODS: A pilot randomized controlled study was conducted at a community pharmacy in Wisconsin, USA. Sixty patients were randomized to either the intervention group who used RxTalk™ during medication pick-up or the control group who did not use the tool. Patients who used RxTalk™ received paper copies of their responses which were also shared with pharmacists. The consultation was audio-recorded for both groups and coded using the Active Patient Participation Coding scale. Follow-up phone interviews were conducted with both groups within one week of enrollment.
RESULTS: Patient tapes were analyzed. In the unadjusted model, patients in the intervention group had a higher active participation rate (p = 0.004) and raised significantly more concerns during consultations (p < 0.001) compared to the control group. Pharmacists asked twice as many questions while counseling patients in the intervention group compared to the control group (p < 0.001). After controlling for patients\' demographics and pharmacists\' questions, there was a statistical difference between the two patient groups in their odds of expressing at least one concern utterance.
CONCLUSIONS: This pilot study suggests that collecting PRO from patients with chronic illnesses and providing results to pharmacists and patients can help patients express their health and medication concerns. RxTalk™ would be useful for pharmacists who wish to improve the recognition and management of medication-related problems.
OBJECTIVE: This study aimed to examine the impact of RxTalk™, a digital PRO tool, in supporting the communication between patients and pharmacists compared to usual care.
METHODS: Intervention: RxTalk™ was developed to collect information about medication adherence and beliefs, using a tablet computer.
METHODS: A pilot randomized controlled study was conducted at a community pharmacy in Wisconsin, USA. Sixty patients were randomized to either the intervention group who used RxTalk™ during medication pick-up or the control group who did not use the tool. Patients who used RxTalk™ received paper copies of their responses which were also shared with pharmacists. The consultation was audio-recorded for both groups and coded using the Active Patient Participation Coding scale. Follow-up phone interviews were conducted with both groups within one week of enrollment.
RESULTS: Patient tapes were analyzed. In the unadjusted model, patients in the intervention group had a higher active participation rate (p = 0.004) and raised significantly more concerns during consultations (p < 0.001) compared to the control group. Pharmacists asked twice as many questions while counseling patients in the intervention group compared to the control group (p < 0.001). After controlling for patients\' demographics and pharmacists\' questions, there was a statistical difference between the two patient groups in their odds of expressing at least one concern utterance.
CONCLUSIONS: This pilot study suggests that collecting PRO from patients with chronic illnesses and providing results to pharmacists and patients can help patients express their health and medication concerns. RxTalk™ would be useful for pharmacists who wish to improve the recognition and management of medication-related problems.
摘要：
背景：数字患者报告结果（PRO）工具的使用已被证明可以增强医疗中的信息交流和共享决策。然而,它们对患者-药剂师相互作用的影响尚未被研究.
目的：本研究旨在检查RxTalk™的影响，一个数字PRO工具，与常规护理相比，支持患者和药剂师之间的沟通。
方法：干预：RxTalk™旨在收集有关药物依从性和信念的信息，使用平板电脑。
方法：在威斯康星州的社区药房进行了一项随机对照试验研究，美国。60名患者被随机分为在药物提取期间使用RxTalk™的干预组或不使用该工具的对照组。使用RxTalk™的患者收到了他们的回复的纸质副本，这些副本也与药剂师分享。对两组的咨询进行音频记录，并使用主动患者参与编码量表进行编码。在招募后一周内对两组进行了后续电话采访。
结果：分析患者胶带。在未调整的模型中，与对照组相比,干预组患者的主动参与率更高(p=0.004),并且在会诊期间提出的关注显著更多(p<0.001).与对照组相比，干预组的药剂师在咨询患者时提出的问题是对照组的两倍（p<0.001）。在控制了患者的人口统计学和药剂师的问题之后，两组患者表达至少一种关注话语的几率有统计学差异.
结论：这项初步研究表明，从慢性病患者中收集PRO并向药剂师和患者提供结果可以帮助患者表达他们的健康和用药问题。RxTalk™对于希望提高对药物相关问题的认识和管理的药剂师是有用的。
目的：本研究旨在检查RxTalk™的影响，一个数字PRO工具，与常规护理相比，支持患者和药剂师之间的沟通。
方法：干预：RxTalk™旨在收集有关药物依从性和信念的信息，使用平板电脑。
方法：在威斯康星州的社区药房进行了一项随机对照试验研究，美国。60名患者被随机分为在药物提取期间使用RxTalk™的干预组或不使用该工具的对照组。使用RxTalk™的患者收到了他们的回复的纸质副本，这些副本也与药剂师分享。对两组的咨询进行音频记录，并使用主动患者参与编码量表进行编码。在招募后一周内对两组进行了后续电话采访。
结果：分析患者胶带。在未调整的模型中，与对照组相比,干预组患者的主动参与率更高(p=0.004),并且在会诊期间提出的关注显著更多(p<0.001).与对照组相比，干预组的药剂师在咨询患者时提出的问题是对照组的两倍（p<0.001）。在控制了患者的人口统计学和药剂师的问题之后，两组患者表达至少一种关注话语的几率有统计学差异.
结论：这项初步研究表明，从慢性病患者中收集PRO并向药剂师和患者提供结果可以帮助患者表达他们的健康和用药问题。RxTalk™对于希望提高对药物相关问题的认识和管理的药剂师是有用的。
